{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:49:51Z","timestamp":1794217791290,"version":"4.8.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Studies on mNGS application in pediatric oncology patients, who are at high risk of infection, are quite limited.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From March 2020 to June 2022, a total of 224 blood samples from 195 pediatric oncology patients who were suspected as bloodstream infections were enrolled in this study. Their clinical and laboratory data were retrospectively reviewed, and the diagnostic performance of mNGS was assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared to the reference tests, mNGS showed significantly higher sensitivity (89.8% vs 32.5%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and clinical agreement (76.3% vs 51.3%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) in detecting potential pathogens and distinguishing BSI from non-BSI. Especially, mNGS had an outstanding\u00a0performance for virus detection, contributing to 100% clinical diagnosed virus. Samples from patients with neutropenia showed higher incidence of bacterial infections (<jats:italic>P<\/jats:italic>\u2009=\u20090.035). The most identified bacteria were <jats:italic>Escherichia coli<\/jats:italic>, and the overall infections by gram-negative bacteria were significantly more prevalent than those by gram-positive ones (90% vs 10%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Overall, mNGS had an impact on the antimicrobial regimens\u2019 usage in 54.3% of the samples in this study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>mNGS has the advantage of rapid and effective pathogen diagnosis in pediatric oncology patients with suspected BSI, especially for virus.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Impact<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>Compared with reference tests, mNGS showed significantly higher sensitivity and clinical agreement in detecting potential pathogens and distinguishing bloodstream infections (BSI) from non-BSI.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>mNGS is particularly prominent in clinical diagnosed virus detection.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>The incidence of bacterial infection was higher in patients with neutropenia, and the overall infection rate of Gram-negative bacteria was significantly higher than that of Gram-positive bacteria.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>mNGS affects the antimicrobial regimens\u2019 usage in more than half of patients.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41390-023-02776-y","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T16:01:54Z","timestamp":1697731314000},"page":"843-851","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Metagenomic next-generation sequencing in detecting pathogens in pediatric oncology patients with suspected bloodstream infections"],"prefix":"10.1038","volume":"95","author":[{"given":"Jing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1196-3190","authenticated-orcid":false,"given":"Yue","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"2776_CR1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1001\/jamaoncol.2019.4120","volume":"6","author":"KP Goggin","year":"2020","unstructured":"Goggin, K. P. et al. Evaluation of plasma microbial cell-free DNA sequencing to predict bloodstream infection in pediatric patients with relapsed or refractory cancer. JAMA Oncol. 6, 552\u2013556 (2020).","journal-title":"JAMA Oncol."},{"key":"2776_CR2","doi-asserted-by":"publisher","first-page":"326","DOI":"10.4149\/neo_2011_04_326","volume":"58","author":"K Katsibardi","year":"2011","unstructured":"Katsibardi, K. et al. Blood stream infections throught the entire course of acute lymphoblastic leukemia treatment. Neoplasma 58, 326\u2013330 (2011).","journal-title":"Neoplasma"},{"key":"2776_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/ijlh.13370","volume":"43","author":"H Shen","year":"2021","unstructured":"Shen, H. et al. Clinical assessment of the utility of metagenomic next-generation sequencing in pediatric patients of hematology department. Int. J. Lab. Hematol. 43, 244\u2013249 (2021).","journal-title":"Int. J. Lab. Hematol."},{"key":"2776_CR4","doi-asserted-by":"publisher","unstructured":"Martinez, R. M. & Wolk, D. M. Bloodstream infections. Microbiol. Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.DMIH2-0031-2016 (2016).","DOI":"10.1128\/microbiolspec.DMIH2-0031-2016"},{"key":"2776_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/jac\/dkw402","volume":"72","author":"SE Battle","year":"2017","unstructured":"Battle, S. E. et al. Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis. J. Antimicrob. Chemother. 72, 299\u2013304 (2017).","journal-title":"J. Antimicrob. Chemother."},{"key":"2776_CR6","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy381","volume":"67","author":"JM Miller","year":"2018","unstructured":"Miller, J. M. et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin. Infect. Dis. 67, e1\u2013e94 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"2776_CR7","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1080\/1040841X.2019.1681933","volume":"45","author":"D Han","year":"2019","unstructured":"Han, D. et al. mNGS in clinical microbiology laboratories: on the road to maturity. Crit. Rev. Microbiol. 45, 668\u2013685 (2019).","journal-title":"Crit. Rev. Microbiol."},{"key":"2776_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jare.2021.09.012","volume":"38","author":"Z Diao","year":"2022","unstructured":"Diao, Z., Han, D., Zhang, R. & Li, J. Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infections. J. Adv. Res. 38, 201\u2013212 (2022).","journal-title":"J. Adv. Res."},{"key":"2776_CR9","doi-asserted-by":"publisher","first-page":"671109","DOI":"10.3389\/fcimb.2021.671109","volume":"11","author":"M Ge","year":"2021","unstructured":"Ge, M. et al. Combining metagenomic sequencing with whole exome sequencing to optimize clinical strategies in neonates with a suspected central nervous system infection. Front. Cell Infect. Microbiol. 11, 671109 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"2776_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1373\/jalm.2018.026120","volume":"3","author":"AL Greninger","year":"2019","unstructured":"Greninger, A. L. & Naccache, S. N. Metagenomics to assist in the diagnosis of bloodstream infection. J. Appl. Lab. Med. 3, 643\u2013653 (2019).","journal-title":"J. Appl. Lab. Med."},{"key":"2776_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22133-y","volume":"8","author":"K Horiba","year":"2018","unstructured":"Horiba, K., Kawada, J. I. & Okuno, Y. Comprehensive detection of pathogens in immunocompromised children with bloodstream infections by next-generation sequencing. Sci. Rep. 8, 3784 (2018).","journal-title":"Sci. Rep."},{"key":"2776_CR12","doi-asserted-by":"publisher","first-page":"100906","DOI":"10.1016\/j.blre.2021.100906","volume":"53","author":"AM Casto","year":"2022","unstructured":"Casto, A. M., Fredricks, D. N. & Hill, J. A. Diagnosis of infectious diseases in immunocompromised hosts using metagenomic next generation sequencing-based diagnostics. Blood Rev. 53, 100906 (2022).","journal-title":"Blood Rev."},{"key":"2776_CR13","doi-asserted-by":"publisher","first-page":"641202","DOI":"10.3389\/fmicb.2021.641202","volume":"12","author":"B Hu","year":"2021","unstructured":"Hu, B. et al. A comparison of blood pathogen detection among droplet digital PCR, metagenomic next-generation sequencing, and blood culture in critically ill patients with suspected bloodstream infections. Front. Microbiol. 12, 641202 (2021).","journal-title":"Front. Microbiol."},{"key":"2776_CR14","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/clinchem\/hvab061","volume":"67","author":"C Jing","year":"2021","unstructured":"Jing, C. et al. Clinical evaluation of an improved metagenomic next-generation sequencing test for the diagnosis of bloodstream infections. Clin. Chem. 67, 1133\u20131143 (2021).","journal-title":"Clin. Chem."},{"key":"2776_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00134-020-05950-6","volume":"46","author":"JF Timsit","year":"2020","unstructured":"Timsit, J. F. et al. Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med. 46, 266\u2013284 (2020).","journal-title":"Intensive Care Med."},{"key":"2776_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jinf.2022.11.020","volume":"86","author":"C Xu","year":"2023","unstructured":"Xu, C. et al. Utility of plasma cell-free DNA next-generation sequencing for diagnosis of infectious diseases in patients with hematological disorders. J. Infect. 86, 14\u201323 (2023).","journal-title":"J. Infect."},{"key":"2776_CR17","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/clinchem\/hvac067","volume":"68","author":"Y Tao","year":"2022","unstructured":"Tao, Y. et al. Diagnostic performance of metagenomic next-generation sequencing in pediatric patients: a retrospective study in a large children\u2019s medical center. Clin. Chem. 68, 1031\u20131041 (2022).","journal-title":"Clin. Chem."},{"key":"2776_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijid.2021.12.335","volume":"116","author":"F Guo","year":"2022","unstructured":"Guo, F., Kang, L. & Zhang, L. mNGS for identifying pathogens in febrile neutropenic children with hematological diseases. Int. J. Infect. Dis. 116, 85\u201390 (2022).","journal-title":"Int. J. Infect. Dis."},{"key":"2776_CR19","doi-asserted-by":"publisher","first-page":"747280","DOI":"10.3389\/fphar.2021.747280","volume":"12","author":"YH Hung","year":"2021","unstructured":"Hung, Y. H. et al. Investigating factors of false-positive results of Aspergillus galactomannan assay: a case-control study in intensive care units. Front. Pharmacol. 12, 747280 (2021).","journal-title":"Front. Pharmacol."},{"key":"2776_CR20","doi-asserted-by":"publisher","first-page":"2000792","DOI":"10.1002\/smtd.202000792","volume":"5","author":"N Li","year":"2021","unstructured":"Li, N. et al. High-throughput metagenomics for identification of pathogens in the clinical settings. Small Methods 5, 2000792 (2021).","journal-title":"Small Methods"},{"key":"2776_CR21","first-page":"1114","volume":"102","author":"Z Diao","year":"2022","unstructured":"Diao, Z., Zhang, R. & Li, J. Analysis of the methods and quality assurance of metagenomic next-generation sequencing to detect the microbial cfDNA from blood samples in China. Natl Med. J. China 102, 1114\u20131118 (2022).","journal-title":"Natl Med. J. China"},{"key":"2776_CR22","doi-asserted-by":"publisher","first-page":"438","DOI":"10.4103\/0019-509X.175311","volume":"51","author":"N Thacker","year":"2014","unstructured":"Thacker, N. et al. Epidemiology of blood stream infections in pediatric patients at a Tertiary Care Cancer Centre. Indian J. Cancer 51, 438\u2013441 (2014).","journal-title":"Indian J. Cancer"},{"key":"2776_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MOH.0000000000000208","volume":"23","author":"DC Dale","year":"2016","unstructured":"Dale, D. C. How I diagnose and treat neutropenia. Curr. Opin. Hematol. 23, 1\u20134 (2016).","journal-title":"Curr. Opin. Hematol."},{"key":"2776_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s15010-013-0525-9","volume":"42","author":"L Nesher","year":"2014","unstructured":"Nesher, L. & Rolston, K. V. The current spectrum of infection in cancer patients with chemotherapy related neutropenia. Infection 42, 5\u201313 (2014).","journal-title":"Infection"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02776-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02776-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02776-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T15:03:38Z","timestamp":1709391818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02776-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["2776"],"URL":"https:\/\/doi.org\/10.1038\/s41390-023-02776-y","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"assertion":[{"value":"12 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Institutional Review Board and the Ethics Committee of Shanghai Children\u2019s Medical Center (SCMCIRB-K2017070), and written informed consent was obtained from each patient and\/or their parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}